UBS Group’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.6M Sell
11,600
-69,560
-86% -$18.5M ﹤0.01% 4054
2026
Q1
$8.9M Buy
81,160
+21,660
+36% +$3.09M ﹤0.01% 3488
2025
Q4
$9.9M Sell
59,500
-3,979
-6% -$666K ﹤0.01% 3295
2025
Q3
$12.4M Buy
+63,479
New +$10.4M ﹤0.01% 3061
2024
Q4
Sell
-10,000
Closed -$524K 10513
2024
Q3
$524K Hold
10,000
﹤0.01% 5191
2024
Q2
$605K Buy
+10,000
New +$694K ﹤0.01% 4853

Other funds holding ALAB

UBS Group's ALAB Position: Q2 2026 in Review

UBS Group reduced its Astera Labs (ALAB) stake by 44% in Q2 2026, selling an estimated $170M and leaving 802,024 shares worth $387M. The position accounts for 0.05% of the portfolio, ranked #385.

UBS Group first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • UBS Group held 802,024 shares of Astera Labs worth $387M as of Q2 2026.
  • UBS Group sold 640,554 Astera Labs shares in Q2 2026, an estimated $170M.
  • Astera Labs made up 0.05% of UBS Group's portfolio in Q2 2026, its #385 holding.
  • UBS Group first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.